Archive
Dealmaker’s Diary: The Rare Disease Fighter Trading at Bargain Prices
This biotech generates positive cash flow while others burn money. At 25x forward earnings, you’re getting tomorrow’s genetic breakthroughs at a discount.
Buy This, Not That: A Tale of Two Balance Sheets
Two tech giants with ugly charts but very different futures…
The Chart Pattern That Scares Billionaires
Markets fell below a critical threshold that legendary trader Paul Tudor Jones warns against. History shows trouble follows when it happens.
Monday Takeaways: Markets at a Crossroads After Finding Support
Markets rally as Trump walks back tariff threats. Shah Gilani explains why crossing 5,700 matters and where hidden risks still lurk.
Market Meltdowns and the Math That Predicts Them
When markets throw tantrums, the VIX reveals their true feelings. Learn to read this drama queen index to time your buys perfectly.
This Payments Processor Just Had an AI-Driven Breakout
This payments processor shows strong fundamentals with 12.5% CROCI, a P/E of 13.7x, and promising AI integration.
Buy This, Not That: The Oil Stock That’s About to Break Out
We pit two oil giants against each other… see which one has better technicals, higher profit margins, lower debt-to-equity ratio, and stronger recovery from recent lows.
The $36 Trillion Reason Markets Are Plunging
Trump and Bessent want investors to panic-sell stocks, pushing cash into Treasurys to lower yields and refinance America’s massive $36 trillion debt.
Monday Takeaways: We’re in Correction Territory… Here’s What’s Coming Next
The S&P 500 dropped more than 10% from its peak in just 16 trading days. Shah reviews key support levels that could determine market direction.
American Exceptionalism Lives in Markets, Not Politics
American capitalism consistently rewards investors across political cycles, with today’s A.I. infrastructure plays following the same pattern as historical winners.